JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG

Their core work

The University of Würzburg is a major German research university with deep strength in quantum materials, photonics, and biomedical sciences. Their H2020 portfolio reveals a university that excels at fundamental research — particularly in condensed matter physics, advanced chemistry, and cancer biology — while also contributing to translational health research in areas like stroke prevention and drug targeting. They are prolific ERC grant winners, reflecting the caliber of their individual researchers, and maintain active training networks (MSCA) that feed Europe's pipeline of early-career scientists in optoelectronics, chronobiology, and molecular biology.

What they specialise in

How they've shifted over time

In 2015–2018, Würzburg's H2020 work centered on physical sciences — optoelectronics, nanophotonics, diamond-based photocatalysis, and quantum materials. The early keyword profile (additive manufacturing, CO2 conversion, green chemistry, sensing) reflects a physics-and-chemistry oriented university. From 2018 onward, a clear shift toward biomedical research emerges: cancer biology (Myc-targeted therapies, organoids, PROTACs), immunology (tissue-resident lymphocytes), and ecological biology (insect chronobiology, circadian rhythms) become dominant themes. The university appears to be broadening from its physics base into translational biomedicine while maintaining its quantum/photonics strength.

Würzburg is pivoting toward translational cancer research (organoids, targeted protein degradation) while sustaining its physics core — expect future projects at the intersection of biophysics and precision oncology.

How they like to work

With 20 out of 55 projects as coordinator (36%), Würzburg frequently leads its own research agenda — especially through ERC grants (22 of 55 projects are ERC-funded), which are by nature PI-driven and coordinator-led. They also participate actively in larger training networks (7 MSCA-ITN projects), showing willingness to join consortia for doctoral training. Their 321 unique partners across 39 countries indicate a broad, non-exclusive network — this is a hub institution that collaborates widely rather than relying on a fixed set of partners.

Würzburg has partnered with 321 distinct organizations across 39 countries, making it one of the more broadly connected German universities. The collaboration footprint is pan-European with strong ties likely to France, Netherlands, UK, and other major research nations based on the project topics.

What sets them apart

Würzburg's distinctive strength is the combination of world-class condensed matter physics (topology, quantum emitters, 2D materials) with a rapidly growing cancer biology program built around MYC oncogene targeting and organoid models. Few European universities can offer this dual depth. Their exceptional ERC success rate (22 grants across Starting, Consolidator, and Advanced categories) signals individual researcher excellence — partnering with Würzburg often means access to ERC-caliber PIs and their research groups.

Highlights from their portfolio

• 4-TOPS
  EUR 2.5M ERC grant on topological superconductivity — coordinator role on one of Europe's flagship quantum materials projects.
• TarMyc
  EUR 1.5M ERC project using PROTAC technology and organoid models to target the MYC oncogene — represents their pivot into translational cancer research.
• DIACAT
  Coordinated a EUR 615K project on diamond-based photocatalysis for CO2-to-fuel conversion — an unusual chemistry-for-energy application reflecting Würzburg's materials versatility.